Clinical Trials Browser

Phase 2 × Terminated × Agammaglobulinemia × Clear all

NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Phase 2 Terminated

3 enrolled 7 charts

LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell